Despite enhanced cross-priming of antigen-specific CD8 T cells upon DC-targeted vaccination, however, memory CD8 T cells were completely lost in CD11c-GSK-3β−/− mice, suggesting that GSK-3β inhibition may ultimately suppress durable antitumor CD8 T cell immunity essential for long-term tumor control. This evidence concerns the gene ITGAX and neoplasm.